Search research articles
Contact Us
Filters
Showing results (51-60 of 65) with videos related to
Page
of 7
Sort By:
Diabetes, Obesity & Metabolism
|
December 15, 2015
New insulin glargine 300 U/ml versus glargine 100 U/ml in Japanese people with type 2 diabetes using basal insulin and oral antihyperglycaemic drugs: glucose control and hypoglycaemia in a randomized controlled trial (EDITION JP 2)
Y Terauchi, M Koyama, X Cheng, et al.
Diabetes & Metabolism
|
June 18, 2017
Glycaemic control and hypoglycaemia with insulin glargine 300U/mL versus insulin glargine 100U/mL in insulin-naïve people with type 2 diabetes: 12-month results from the EDITION 3 trial
G B Bolli, M C Riddle, R M Bergenstal, et al.
Diabetes & Metabolism
|
April 24, 2017
Glycaemic control and hypoglycaemia with insulin glargine 300 U/mL compared with glargine 100 U/mL in Japanese adults with type 2 diabetes using basal insulin plus oral anti-hyperglycaemic drugs (EDITION JP 2 randomised 12-month trial including 6-month extension)
Y Terauchi, M Koyama, X Cheng, et al.
Diabetes, Obesity & Metabolism
|
December 15, 2015
New insulin glargine 300 U/ml versus glargine 100 U/ml in Japanese adults with type 1 diabetes using basal and mealtime insulin: glucose control and hypoglycaemia in a randomized controlled trial (EDITION JP 1)
M Matsuhisa, M Koyama, X Cheng, et al.
Diabetes, Obesity & Metabolism
|
June 13, 2014
Greater fear of hypoglycaemia with premixed insulin than with basal-bolus insulin glargine and glulisine: patient-reported outcomes from a 60-week randomised study
W H Polonsky, S Thompson, W Wei, et al.
Patient Education and Counseling
|
January 10, 1998
Long-term effects and costs of brief behavioural dietary intervention for patients with diabetes delivered from the medical office
R E Glasgow, P A La Chance, D J Toobert, et al.
Diabetes, Obesity & Metabolism
|
February 3, 2015
New insulin glargine 300 U/ml compared with glargine 100 U/ml in insulin-naïve people with type 2 diabetes on oral glucose-lowering drugs: a randomized controlled trial (EDITION 3)
G B Bolli, M C Riddle, R M Bergenstal, et al.
Diabetes, Obesity & Metabolism
|
April 8, 2015
One-year sustained glycaemic control and less hypoglycaemia with new insulin glargine 300 U/ml compared with 100 U/ml in people with type 2 diabetes using basal plus meal-time insulin: the EDITION 1 12-month randomized trial, including 6-month extension
M C Riddle, H Yki-Järvinen, G B Bolli, et al.
Diabetes, Obesity & Metabolism
|
June 5, 2015
Fixed ratio dosing of pramlintide with regular insulin before a standard meal in patients with type 1 diabetes
M C Riddle, K C J Yuen, T W de Bruin, et al.
Diabetes & Metabolism
|
December 27, 2017
Assessment of hypoglycaemia during basal insulin therapy: Temporal distribution and risk of events using a predefined or an expanded definition of nocturnal events
M C Riddle, G B Bolli, A Avogaro, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 65) with videos related to
Sort By:
Page
of 7
Diabetes, Obesity & Metabolism
|
December 15, 2015
New insulin glargine 300 U/ml versus glargine 100 U/ml in Japanese people with type 2 diabetes using basal insulin and oral antihyperglycaemic drugs: glucose control and hypoglycaemia in a randomized controlled trial (EDITION JP 2)
Y Terauchi, M Koyama, X Cheng, et al.
Diabetes & Metabolism
|
June 18, 2017
Glycaemic control and hypoglycaemia with insulin glargine 300U/mL versus insulin glargine 100U/mL in insulin-naïve people with type 2 diabetes: 12-month results from the EDITION 3 trial
G B Bolli, M C Riddle, R M Bergenstal, et al.
Diabetes & Metabolism
|
April 24, 2017
Glycaemic control and hypoglycaemia with insulin glargine 300 U/mL compared with glargine 100 U/mL in Japanese adults with type 2 diabetes using basal insulin plus oral anti-hyperglycaemic drugs (EDITION JP 2 randomised 12-month trial including 6-month extension)
Y Terauchi, M Koyama, X Cheng, et al.
Diabetes, Obesity & Metabolism
|
December 15, 2015
New insulin glargine 300 U/ml versus glargine 100 U/ml in Japanese adults with type 1 diabetes using basal and mealtime insulin: glucose control and hypoglycaemia in a randomized controlled trial (EDITION JP 1)
M Matsuhisa, M Koyama, X Cheng, et al.
Diabetes, Obesity & Metabolism
|
June 13, 2014
Greater fear of hypoglycaemia with premixed insulin than with basal-bolus insulin glargine and glulisine: patient-reported outcomes from a 60-week randomised study
W H Polonsky, S Thompson, W Wei, et al.
Patient Education and Counseling
|
January 10, 1998
Long-term effects and costs of brief behavioural dietary intervention for patients with diabetes delivered from the medical office
R E Glasgow, P A La Chance, D J Toobert, et al.
Diabetes, Obesity & Metabolism
|
February 3, 2015
New insulin glargine 300 U/ml compared with glargine 100 U/ml in insulin-naïve people with type 2 diabetes on oral glucose-lowering drugs: a randomized controlled trial (EDITION 3)
G B Bolli, M C Riddle, R M Bergenstal, et al.
Diabetes, Obesity & Metabolism
|
April 8, 2015
One-year sustained glycaemic control and less hypoglycaemia with new insulin glargine 300 U/ml compared with 100 U/ml in people with type 2 diabetes using basal plus meal-time insulin: the EDITION 1 12-month randomized trial, including 6-month extension
M C Riddle, H Yki-Järvinen, G B Bolli, et al.
Diabetes, Obesity & Metabolism
|
June 5, 2015
Fixed ratio dosing of pramlintide with regular insulin before a standard meal in patients with type 1 diabetes
M C Riddle, K C J Yuen, T W de Bruin, et al.
Diabetes & Metabolism
|
December 27, 2017
Assessment of hypoglycaemia during basal insulin therapy: Temporal distribution and risk of events using a predefined or an expanded definition of nocturnal events
M C Riddle, G B Bolli, A Avogaro, et al.
Page
of 7